NEUP NASDAQ
Neuphoria Therapeutics Inc.
1W: -4.9%
1M: -7.5%
3M: +0.9%
YTD: -9.2%
1Y: -75.0%
3Y: -70.6%
$3.47
-0.04 (-1.14%)
Weekly Expected Move ±2.0%
$3
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$18.8M
52W Range3.19-21.4
Volume12,362
Avg Volume145,103
Beta0.75
Dividend—
Analyst Ratings
Company Info
CEOSpyridon Papapetropoulos
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2021-12-16
Websiteneuphoriatx.com
100 Summit Dr
Burlington, MA 01803
US
Burlington, MA 01803
US
About Neuphoria Therapeutics Inc.
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Latest News
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
Deal Dispatch: GoPro Retains Houlihan Lokey In Strategic Review, Brookfield Buys World Freight Company, YesCare Corp. Bankruptcy
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria's Director Nominees
Neuphoria Responds to Lynx1's Revised Indication of Interest at a Reduced Price and Premium
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Wilson David Ian | A-Award | 8,537 | — | 2026-01-20 |
| Davies Peter Miles W | A-Award | 8,537 | — | 2026-01-20 |
| Fisher Alan | A-Award | 17,073 | — | 2026-01-20 |
| Ryan Jane | A-Award | 8,537 | — | 2026-01-20 |
| Lynx1 Capital Manage | P-Purchase | 639,110 | $5.14 | 2025-10-21 |